Skip to main content

Advertisement

Figure 2 | Cancer Cell International

Figure 2

From: Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo

Figure 2

The Comparison of Nova and rhIFN-α2b in anti-virus/tumor activity. The anti-tumor (A) and anti-virus (B) activity of Nova and rhIFN-α2b determined by WISH-VSV system and Daudi-MTT assay, :rhIFN-α2b, Δ: Nova, Ο: IFN-α international standard control; The column demonstration of anti-tumor (C) and anti-virus activity (D) of Nova and IFN-α2b, **, P < 0.01, compared with IFN-α2b.

Back to article page